BMJ  2007;335:317 (18 August), doi:10.1136/bmj.39303.690752.3A

Letters

Payment for treatment adherence

Incentives help vulnerable patients to stay well

The first 150 words of the full text of this article appear below.

In the head to head debate, Shaw says that to pay patients to take medication would create perverse incentives, but in her discussion she dismisses a particularly complex group of patients, with tuberculosis, despite the public health issues involved.^{1 2} This is a group of patients for whom payment, or other forms of incentive, are of critical importance, at both the individual and the public health level. For these patients, health is very low on their list of priorities—they tend to be those suffering from social exclusion, often with histories of offending, substance abuse, mental health problems, and homelessness. They require the most complex care and are least likely to complete treatment, particularly when the course of treatment is lengthy.³

It is common practice in tuberculosis teams to carry out a standard risk assessment with each patient and to offer incentives to those who would be at high risk of non-completion . . . [Full text of this article]

Homerton University Hospital, London E9 6SR

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Articles

Is it acceptable for people to be paid to adhere to medication? Yes

Tom Burns
BMJ 2007 335: 232. [Extract] [Full Text] [PDF]

Is it acceptable for people to be paid to adhere to medication? No

Joanne Shaw
BMJ 2007 335: 233. [Extract] [Full Text] [PDF]

Systematic review of randomised controlled trials of strategies to promote adherence to tuberculosis treatment

Jimmy Volmink and Paul Garner
BMJ 1997 315: 1403-1406. [Abstract] [Full Text]

This article has been cited by other articles:

• Byrne, A. (2007). Methadone works if used properly. BMJ 335: 464-464 [Full text]  

Online poll

Find out more >>